Cellmid 2017 Annual Report 35
STATEMENT OF
CASH FLOWS
The above Statement of Cashflows should be read in conjunction with the accompanying notes.
AT AS 30 JUNE 2017
2017 2016
Note $ $
CASH FLOWS FROM OPERATING ACTIVITIES:
Receipts from customers 5,001,390 3,803,555
Payments to suppliers and employees (9,823,291) (7,402,022)
Interest received 56,956 39,509
Grant income 831,408 1,121,562
Finance costs (126,982) (111,316)
Net cash used in operating activities 21 (4,060,519) (2,548,712)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of non current assets (35,877) (32,928)
Net cash used in investing activities (35,877) (32,928)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issue of shares (net of share issue costs) 4,074,104 3,725,515
Proceeds from Loans and borrowings 1,867,960 962,800
Repayments of Loans and borrowings (498,277) (1,044,009)
Net cash provided by financing activities 5,443,787 3,644,306
Net increase in cash and cash equivalents held 1,347,391 1,062,666
Cash and cash equivalents at beginning of financial year 2,686,329 1,582,899
Effect of exchange rate changes (39,079) 40,764
Cash and cash equivalents at end of financial year 9 3,994,641 2,686,329
Consolidated